Kovács Mária, Kiss Attila, Gönczi Márton, Miskolczi Gottfried, Seprényi György, Kaszaki József, Kohr Mark J, Murphy Elizabeth, Végh Ágnes
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Department of Medical Biology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
PLoS One. 2015 Apr 24;10(4):e0122243. doi: 10.1371/journal.pone.0122243. eCollection 2015.
To provide evidence for the protective role of inorganic nitrite against acute ischaemia and reperfusion-induced ventricular arrhythmias in a large animal model.
Dogs, anaesthetized with chloralose and urethane, were administered intravenously with sodium nitrite (0.2 µmol kg(-1) min(-1)) in two protocols. In protocol 1 nitrite was infused 10 min prior to and during a 25 min occlusion of the left anterior descending (LAD) coronary artery (NaNO2-PO; n = 14), whereas in protocol 2 the infusion was started 10 min prior to reperfusion of the occluded vessel (NaNO2-PR; n = 12). Control dogs (n = 15) were infused with saline and subjected to the same period of ischaemia and reperfusion. Severities of ischaemia and ventricular arrhythmias, as well as changes in plasma nitrate/nitrite (NOx) levels in the coronary sinus blood, were assessed throughout the experiment. Myocardial superoxide and nitrotyrosine (NT) levels were determined during reperfusion. Changes in protein S-nitrosylation (SNO) and S-glutathionylation were also examined.
Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs. 50 and 92%) upon reperfusion. There were also significant decreases in superoxide and NT levels in the nitrite treated dogs. Compared with controls, increased SNO was found only in NaNO2-PR dogs, whereas S-glutathionylation occurred primarily in NaNO2-PO dogs.
Intravenous infusion of nitrite profoundly reduced the severity of ventricular arrhythmias resulting from acute ischaemia and reperfusion in anaesthetized dogs. This effect, among several others, may result from an NO-mediated reduction in oxidative stress, perhaps through protein SNO and/or S-glutathionylation.
在大型动物模型中,为无机亚硝酸盐对急性缺血及再灌注诱发的室性心律失常的保护作用提供证据。
用氯醛糖和氨基甲酸乙酯麻醉的犬,按两种方案静脉给予亚硝酸钠(0.2 μmol·kg⁻¹·min⁻¹)。在方案1中,于左前降支(LAD)冠状动脉闭塞25分钟前及闭塞期间输注亚硝酸盐(NaNO₂-PO;n = 14),而在方案2中,于闭塞血管再灌注前10分钟开始输注(NaNO₂-PR;n = 12)。对照犬(n = 15)输注生理盐水,并经历相同时长的缺血和再灌注。在整个实验过程中评估缺血和室性心律失常的严重程度,以及冠状窦血中血浆硝酸盐/亚硝酸盐(NOₓ)水平的变化。在再灌注期间测定心肌超氧化物和硝基酪氨酸(NT)水平。还检测了蛋白质S-亚硝基化(SNO)和S-谷胱甘肽化的变化。
与对照组相比,在闭塞前或再灌注前给予亚硝酸钠可显著抑制闭塞期间室性心律失常的数量和严重程度,并提高再灌注时的存活率(0% 对 50% 和 92%)。亚硝酸盐处理的犬中超氧化物和NT水平也显著降低。与对照组相比,仅在NaNO₂-PR犬中发现SNO增加,而S-谷胱甘肽化主要发生在NaNO₂-PO犬中。
静脉输注亚硝酸盐可显著降低麻醉犬急性缺血和再灌注所致室性心律失常的严重程度。这种作用可能是由NO介导的氧化应激降低所致,或许是通过蛋白质SNO和/或S-谷胱甘肽化。